Applied Clinical Trials Digital Edition - November 2010
SURVEY : 2010 Salary & Satisfaction Survey CRO/SPONSOR : Mergers and Acquisitions Prevalent in Pharma LABS : Discordance Between BICR Readers Also in this issue : $500 Million a Year Earmarked for Disease Research, EMA Addresses Possible Conflicts of Interest, Investigative Sites in Financial Trouble, Suicide Risk Monitoring
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
First Patient Dosed in Phase III Trial of Enhertu as First-Line Treatment for Endometrial Cancer
June 10th 2025In combination with rilvegostomig or Keytruda, Enhertu will be evaluated versus chemotherapy in the DESTINY-Endometrial01 study for the treatment of patients with HER2-expressing, mismatch repair proficient primary advanced or recurrent endometrial cancer.
